Bioconjugates pose complex development and manufacturing challenges. This brochure describes Lonza's manufacturing capabilities and the advantages of its simplified supply chain in which intermediates and the drug substance are manufactured under one quality system, reducing risk and accelerating the timeline to clinical trials and market. To learn more, please see our brochure.
Latest content

Latest briefing from the Knowledge Center